Article Versions Notes

Arany P, Róka E, Mollet L, Coleman AW, Perret F, Kim B, Kovács R, Kazsoki A, Zelkó R, Gesztelyi R, et al. Fused Deposition Modeling 3D Printing: Test Platforms for Evaluating Post-Fabrication Chemical Modifications and In-Vitro Biological Properties. Pharmaceutics. 2019; 11(6):277. https://doi.org/10.3390/pharmaceutics11060277

Arany, Petra, Eszter Róka, Laurent Mollet, Anthony W. Coleman, Florent Perret, Beomjoon Kim, Renátó Kovács, Adrienn Kazsoki, Romána Zelkó, Rudolf Gesztelyi, and et al. 2019. "Fused Deposition Modeling 3D Printing: Test Platforms for Evaluating Post-Fabrication Chemical Modifications and In-Vitro Biological Properties" Pharmaceutics 11, no. 6: 277. https://doi.org/10.3390/pharmaceutics11060277

Arany, P., Róka, E., Mollet, L., Coleman, A. W., Perret, F., Kim, B., Kovács, R., Kazsoki, A., Zelkó, R., Gesztelyi, R., Ujhelyi, Z., Fehér, P., Váradi, J., Fenyvesi, F., Vecsernyés, M., & Bácskay, I. (2019). Fused Deposition Modeling 3D Printing: Test Platforms for Evaluating Post-Fabrication Chemical Modifications and In-Vitro Biological Properties. Pharmaceutics, 11(6), 277. https://doi.org/10.3390/pharmaceutics11060277